🇺🇸 FDA
Patent

US 10716770

Nicotinic receptor non-competitive antagonists

granted A61KA61K31/13A61K31/397

Quick answer

US patent 10716770 (Nicotinic receptor non-competitive antagonists) held by Catalyst Biosciences, Inc. expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/13, A61K31/397, A61K31/40, A61P